These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1333898)

  • 1. Radiotherapy of cholangiocarcinoma: the roles for primary and adjuvant therapies.
    Shiina T; Mikuriya S; Uno T; Toita T; Serizawa S; Itami J; Kawai S; Tani M
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S115-8. PubMed ID: 1333898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does additive radiotherapy after hilar resection improve survival of cholangiocarcinoma? An analysis in sixty-four patients.
    Verbeek PC; Van Leeuwen DJ; Van Der Heyde MN; Gonzalez Gonzalez D
    Ann Chir; 1991; 45(4):350-4. PubMed ID: 1648329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
    Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant obstructive jaundice: treatment with external-beam and intracavitary radiotherapy.
    Johnson DW; Safai C; Goffinet DR
    Int J Radiat Oncol Biol Phys; 1985 Feb; 11(2):411-6. PubMed ID: 2579052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External beam and intraluminal radiotherapy for locally advanced bile duct cancer: role and tolerability.
    Vallis KA; Benjamin IS; Munro AJ; Adam A; Foster CS; Williamson RC; Kerr GR; Price P
    Radiother Oncol; 1996 Oct; 41(1):61-6. PubMed ID: 8961369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma.
    González González D; Gouma DJ; Rauws EA; van Gulik TM; Bosma A; Koedooder C
    Ann Oncol; 1999; 10 Suppl 4():215-20. PubMed ID: 10436826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of radiotherapy in the treatment of bile duct carcinoma.
    Veeze-Kuijpers B; Meerwaldt JH; Lameris JS; van Blankenstein M; van Putten WL; Terpstra OT
    Int J Radiat Oncol Biol Phys; 1990 Jan; 18(1):63-7. PubMed ID: 2153649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable low dose rate irradiation (131I-anti-CEA) and integrated low dose chemotherapy in the treatment of nonresectable primary intrahepatic cholangiocarcinoma.
    Stillwagon GB; Order SE; Haulk T; Herpst J; Ettinger DS; Fishman EK; Klein JL; Leichner PK
    Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1601-5. PubMed ID: 1657845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-modality treatment of primary nonresectable intrahepatic cholangiocarcinoma with 131I anti-CEA--a Radiation Therapy Oncology Group Study.
    Stillwagon GB; Order SE; Klein JL; Leichner PK; Leibel SA; Siegelman SS; Fishman EK; Ettinger DS; Haulk T; Kopher K
    Int J Radiat Oncol Biol Phys; 1987 May; 13(5):687-95. PubMed ID: 3032877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pretreatment cholinesterase level on survival of inoperable intrahepatic or hepatic-hilar carcinomas treated with three-dimensional conformal radiotherapy.
    Hamamoto Y; Niino K; Ishiyama H; Hosoya T
    Radiat Med; 2004; 22(5):316-23. PubMed ID: 15553012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External radiotherapy for biliary decompression of hilar cholangiocarcinoma.
    Ohnishi H; Asada M; Shichijo Y; Iijima N; Itobayashi E; Shimura K; Suzuki T; Yoshida S; Mine T
    Hepatogastroenterology; 1995 Jul; 42(3):265-8. PubMed ID: 7590576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma.
    Gerhards MF; van Gulik TM; González González D; Rauws EA; Gouma DJ
    World J Surg; 2003 Feb; 27(2):173-9. PubMed ID: 12616432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine.
    Lawrence TS; Dworzanin LM; Walker-Andrews SC; Andrews JC; Ten Haken RK; Wollner IS; Lichter AS; Ensminger WD
    Int J Radiat Oncol Biol Phys; 1991 Mar; 20(3):555-61. PubMed ID: 1847363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of failure after curative irradiation of extrahepatic bile duct carcinoma.
    Buskirk SJ; Gunderson LL; Schild SE; Bender CE; Williams HJ; McIlrath DC; Robinow JS; Tremaine WJ; Martin JK
    Ann Surg; 1992 Feb; 215(2):125-31. PubMed ID: 1312319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation of intrahepatic cholangiocarcinoma: feasability, local tumor control, and long-term outcome.
    Butros SR; Shenoy-Bhangle A; Mueller PR; Arellano RS
    Clin Imaging; 2014; 38(4):490-494. PubMed ID: 24637151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of radiation therapy in carcinoma of the proximal bile duct (Klatskin tumor).
    González González D; Gerard JP; Maners AW; De la Lande-Guyaux B; Van Dijk-Milatz A; Meerwaldt JH; Bosset JF; Van Dijk JD
    Semin Liver Dis; 1990 May; 10(2):131-41. PubMed ID: 2162565
    [No Abstract]   [Full Text] [Related]  

  • 17. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival.
    Pitt HA; Nakeeb A; Abrams RA; Coleman J; Piantadosi S; Yeo CJ; Lillemore KD; Cameron JL
    Ann Surg; 1995 Jun; 221(6):788-97; discussion 797-8. PubMed ID: 7794082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraluminal brachytherapy in bile duct carcinomas.
    Leung J; Guiney M; Das R
    Aust N Z J Surg; 1996 Feb; 66(2):74-7. PubMed ID: 8602818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival after intraluminal brachytherapy for inoperable hilar cholangiocarcinoma: a case report.
    Chan SY; Poon RT; Ng KK; Liu CL; Chan RT; Fan ST
    World J Gastroenterol; 2005 May; 11(20):3161-4. PubMed ID: 15918211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined external beam radiotherapy and intraluminal high dose rate brachytherapy on bile duct carcinomas.
    Fritz P; Brambs HJ; Schraube P; Freund U; Berns C; Wannenmacher M
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):855-61. PubMed ID: 8040034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.